SMTL ID : 5zan.1

Crystal Structure of Aurora-A in complex with a new Quinazoline inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

monomer

Ligands

1 x 9A6: 7-(4-methylpiperazin-1-yl)-N-(5-methyl-1H-pyrazol-3-yl)-2-[(E)-2-phenylethenyl]quinazolin-4-amine(Non-covalent)

9A6.1: 15 residues within 4Å: Chain A: R.15, L.17, G.18, K.19, G.20, V.25, A.38, E.89, Y.90, A.91, P.92, L.93, G.94, E.99, L.141 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.17, A:V.25, A:V.25, A:A.38, A:L.141 Hydrogen bonds: A:E.89, A:A.91, A:A.91 Salt bridges: A:E.99

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Long, L. et al., Optimization of Novel Quinazolines as Potent and Orally Bioavailable Aurora Kinase Inhibitors. To Be Published

Release Date

2019-02-13

Peptides

Aurora kinase A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aurora kinase A